Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “All Acute Pediatric Conditions”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03573700
What this trial is testing

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, Refractory
St. Jude Children's Research Hospital 24
Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Not applicableStudy completedNCT03627208
What this trial is testing

Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch

Who this might be right for
Leukemia, Lymphoblastic, AcuteALL, Childhood
National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT00077467
What this trial is testing

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36
Not applicableNo Longer AvailableNCT02187354
What this trial is testing

Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL

Who this might be right for
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Amgen
Not applicableStudy completedNCT00898079
What this trial is testing

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChildhood Acute Lymphoblastic Leukemia+11 more
Children's Oncology Group 2,545
Not applicableUnknownNCT01104324
What this trial is testing

Osteonecrosis in Children With Acute Lymphoblastic Leukemia

Who this might be right for
OsteonecrosisAcute Lymphoblastic Leukemia
Halton, Jacqueline, M.D. 130
Not applicableLooking for participantsNCT05929976
What this trial is testing

InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort

Who this might be right for
Acute Lymphoblastic LeukemiaNutrition Aspect of CancerMicrotia+1 more
Columbia University 4,900
Early research (Phase 1)Ended earlyNCT00101205
What this trial is testing

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01471782
What this trial is testing

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 93
Early research (Phase 1)Looking for participantsNCT06559189
What this trial is testing

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
University of Colorado, Denver 53
Not applicableStudy completedNCT05506683
What this trial is testing

Improving Nighttime Access to Care and Treatment; Part 2- Ghana

Who this might be right for
Pediatric ALLAcute Disease
University of Florida 1,239
Not applicableStudy completedNCT00899015
What this trial is testing

Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J

Who this might be right for
LeukemiaLymphoma
National Institutes of Health Clinical Center (CC) 23
Testing effectiveness (Phase 2)Study completedNCT01036009
What this trial is testing

Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 43
Testing effectiveness (Phase 2)Looking for participantsNCT05082519
What this trial is testing

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaObesity
Etan Orgel 240
Not applicableStudy completedNCT01663129
What this trial is testing

Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study

Who this might be right for
Acute Lymphoblastic LeukemiaNephrotic SyndromeRheumatism
Children's Hospital of Eastern Ontario 406
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT05642117
What this trial is testing

Pediatric Telephone Center Board 15

Who this might be right for
EmergenciesPediatric ALLResponse, Acute Phase
University Hospital, Brest 785
Testing effectiveness (Phase 2)WithdrawnNCT05740449
What this trial is testing

HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Not applicableLooking for participantsNCT07327138
What this trial is testing

Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.

Who this might be right for
Acute Lymphoblastic Leukemia ALL
Bahaa Bou Dargham 60
Next Page